Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03423836 · ClinicalTrials.gov registry record
Maternal Oral Therapy to Reduce Obstetric Risk Kids
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 331
- Enrollment target
NCT03423836: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT03423836 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 331 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03423836 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 331 participants
- Enrollment target
Study Summary
The principal objective was to conduct a 5 year; multi-center, observational follow-up study enrolling infants born to mothers who participated in the MOTOR clinical trial to determine the effects of maternal periodontal therapy during pregnancy on neonatal morbidity and mortality and whether this will result in lower incidence of functional neurological impairment.
Primary Outcome
MCHAT composite risk score for Autism questionnaire is a 20-item screening tool completed by parents of children aged 16-30 months to evaluate Autism Spectrum Disorder (ASD) risk. Score ranges include 0 to 20 with 2 or less indicating low-risk, 3-7 medium-risk and 8-20 indicating high-risk.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 331 participants |
| Start Date | 2007-04-30 |
| Est. Completion | 2013-01-11 |
What the finished NCT03423836 record still lists
NCT03423836 is an observational study that tracks outcomes without assigning an intervention. The registered 331 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03423836 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03423836 about?
NCT03423836 is a clinical study titled "Maternal Oral Therapy to Reduce Obstetric Risk Kids". The principal objective was to conduct a 5 year; multi-center, observational follow-up study enrolling infants born to mothers who participated in the MOTOR clinical trial to determine the effects of maternal periodontal therapy during pregnancy on neonatal morbidity and mortality and whether this w...
What is the current status of trial NCT03423836?
This trial is currently completed. The enrollment target is 331 participants. The study started on 2007-04-30. Estimated completion is 2013-01-11.
Who is sponsoring clinical trial NCT03423836?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI